Breaking Down Akzo Nobel N.V. Financial Health: Key Insights for Investors

Breaking Down Akzo Nobel N.V. Financial Health: Key Insights for Investors

NL | Basic Materials | Chemicals - Specialty | EURONEXT

Akzo Nobel N.V. (AKZA.AS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

From steady margins to rising leverage, Akzo Nobel's 2025 performance demands a close read: revenue slid from €2.61 billion in Q1 (down 1% YoY) to €2.63bn in Q2 (down 6%) and €2.58bn in Q3 (down 5%) as currency headwinds weighed even while organic sales largely stayed flat and decorative paints made up 40% of 2024 sales; profitability showed resilience with Q1 adjusted EBITDA of €357 million (a 13.7% margin) and subsequent quarters expanding margins to 15.0% and 15.1% on efficiency actions and a 2024 adjusted EBITDA margin of 14.3%, but balance-sheet pressures are clear - total debt stood at €5.4 billion versus equity of €4.1bn (debt/equity 129.1%), net debt rose to €4.11 billion (leverage 2.8x) despite plans to cut net debt toward €2bn, and liquidity moves include €1.3bn cash and the JSW India sale expected to close in Q4 2025; analysts see upside - JPMorgan's €70 PT and an average one‑year target of €73.72 (implying ~47% upside) alongside a 3.96% dividend yield - yet risks from tariffs, currency swings, and restructuring remain, so read on for a quarter-by-quarter breakdown, solvency analysis, valuation context, and what the planned efficiency savings of over €150 million by end‑2025 mean for investors.

Akzo Nobel N.V. (AKZA.AS) - Revenue Analysis

Akzo Nobel reported a pattern of modest revenue declines through the first three quarters of fiscal 2025, with variation driven largely by currency headwinds while underlying (organic) demand showed resilience. Strategic pricing and ongoing cost-reduction measures supported profitability despite topline pressure. Key quarter figures and drivers are summarized below.

  • Q1 2025 revenue: €2.61 billion (down 1% year‑on‑year); organic sales flat.
  • Q2 2025 revenue: €2.63 billion (down 6% YoY); adverse currency effects were the primary cause; organic sales flat.
  • Q3 2025 revenue: €2.58 billion (down 5% YoY); unfavorable FX impacts persisted but organic sales rose 1%.
  • Management expects a slight year‑over‑year decrease in adjusted EBITDA for Q1 2025, consistent with market expectations.
Quarter Revenue (€bn) YoY % Change Organic Sales Change Primary Driver
Q1 2025 2.61 -1% 0% Flat demand; slight FX headwind
Q2 2025 2.63 -6% 0% Adverse currency effects
Q3 2025 2.58 -5% +1% FX headwinds offset by modest organic growth

The company's 2024 revenue mix remains diversified and offers context for segment exposure:

  • Decorative paints: 40%
  • Industrial coatings: 19%
  • Powder coatings: 13%
  • Automotive & specialty coatings: 13%
  • Marine & protective coatings: 15%

Drivers of margin resilience and profitability:

  • Strategic pricing actions preserved margins as input costs normalized in parts of 2025.
  • Ongoing cost reduction and efficiency programs limited EBITDA deterioration despite revenue declines.
  • Geographic and product mix diversity reduced reliance on any single end market amid FX volatility.

For broader context on the company's background, strategy and how it generates revenue, see: Akzo Nobel N.V.: History, Ownership, Mission, How It Works & Makes Money

Akzo Nobel N.V. (AKZA.AS) - Profitability Metrics

Akzo Nobel's recent results show stable to improving profitability driven by margin expansion and efficiency measures across 2025, supported by a historically healthy gross margin and a long track record of shareholder returns.

  • Adjusted EBITDA progression (2025): Q1 €357m (13.7% adj. EBITDA margin), Q2 €393m (15.0%), Q3 €385m (15.1%).
  • Year‑over‑year margin trend: Q2 2025 margin rose from 14.4% in Q2 2024 to 15.0% in Q2 2025; company 2024 adjusted EBITDA margin was 14.3%.
  • Gross profit margin: 40.8%, indicating strong operational efficiency and healthy pricing/COGS dynamics.
  • Dividend pedigree: 33 consecutive years of dividend payments, signaling continued commitment to shareholder returns.
  • Drivers: cost‑savings and efficiency actions cited as primary contributors to 2025 margin improvements.
Period Adjusted EBITDA (€m) Adjusted EBITDA Margin Notes
Q1 2025 357 13.7% In line with prior year
Q2 2025 393 15.0% Improved vs Q2 2024 (14.4%); efficiency actions
Q3 2025 385 15.1% Margin expansion from continued cost savings
Full year 2024 (reference) - 14.3% Baseline year margin
Gross profit margin - 40.8% Operational efficiency indicator
Dividend track record - 33 years Consistent shareholder returns

For background on the company's strategy, ownership and how it generates revenue, see: Akzo Nobel N.V.: History, Ownership, Mission, How It Works & Makes Money

Akzo Nobel N.V. (AKZA.AS) Debt vs. Equity Structure

As of March 2025, Akzo Nobel shows a capital structure tilted toward debt, with several key metrics that investors should track for risk and return assessment. The company's leverage and liquidity position reflect both operational cash generation and financing choices as it executes deleveraging plans.
  • Total debt: €5.4 billion (Mar 2025)
  • Total equity: €4.1 billion (Mar 2025)
  • Debt-to-equity ratio: 129.1%
  • Net debt (Q1 2025): €4.11 billion - leverage ratio: 2.8x (above mid-term target)
  • Interest coverage ratio: 5x
  • Cash and short-term investments: €1.3 billion
  • Total assets: €13.9 billion; Total liabilities: €9.8 billion
  • Mid-term target: reduce net debt to ≈ €2.0 billion and leverage ≈ 2.0x
Metric Value (Mar 2025 / Q1 2025)
Total debt €5.4 billion
Total equity €4.1 billion
Debt-to-equity ratio 129.1%
Net debt €4.11 billion
Leverage (Net debt / EBITDA) 2.8x
Interest coverage ratio 5x
Cash & short-term investments €1.3 billion
Total assets €13.9 billion
Total liabilities €9.8 billion
Target net debt (mid-term) ≈ €2.0 billion
Target leverage (mid-term) ≈ 2.0x
Key implications for investors:
  • Current debt-heavy structure (D/E 129.1%) amplifies financial risk but is partially offset by a solid interest coverage ratio (5x).
  • Net debt of €4.11bn and leverage of 2.8x exceed the stated mid-term threshold (<2.5x), so progress on deleveraging will be a monitoring focus.
  • €1.3bn in cash and short-term investments provides operational liquidity and optionality for debt repayment or strategic investments.
  • Achieving the target net debt of ~€2bn would materially improve the capital structure and lower financial risk, moving leverage toward ~2.0x.
For broader investor context and shareholder activity related to this capital structure, see: Exploring Akzo Nobel N.V. Investor Profile: Who's Buying and Why?

Akzo Nobel N.V. (AKZA.AS) - Liquidity and Solvency

Akzo Nobel's short-term liquidity and longer-term solvency dynamics in 2024-2025 show a mix of operational swings, targeted disposals and cost actions aimed at strengthening the balance sheet.
  • Operating cash flow volatility: Q1 2025 net cash from operating activities was negative €112 million (improved from negative €170 million in Q1 2024); Q2 2025 turned positive at €234 million (up from €151 million in Q2 2024).
  • Leverage: net debt-to-EBITDA rose to ~3.0x in Q3 2024, primarily driven by temporarily elevated working capital.
  • Interest coverage: an interest coverage ratio of ~5x indicates a strong capacity to service interest expense under current EBIT levels.
  • Balance-sheet support measures: binding agreement to sell Akzo Nobel India to the JSW Group (expected close Q4 2025) and restructuring initiatives targeting annualized gross savings >€150 million by end-2025.
Metric Q1 2024 Q1 2025 Q2 2024 Q2 2025 Q3 2024
Net cash from operating activities (€m) -170 -112 151 234 -
Net debt-to-EBITDA (x) - - - - 3.0
Interest coverage (x) - - - - 5.0
Projected annualized gross savings (€m) - - - - 150+
  • Key near-term liquidity events to monitor:
    • Closing of Akzo Nobel India sale to JSW Group (expected Q4 2025) - potential one-off cash inflow improving headroom.
    • Realization of restructuring savings (>€150m gross annualized) - improves free cash flow and deleveraging potential.
For additional context on shareholder and investor positioning, see: Exploring Akzo Nobel N.V. Investor Profile: Who's Buying and Why?

Akzo Nobel N.V. (AKZA.AS) - Valuation Analysis

  • JPMorgan: Overweight, price target €70.00; expects ~9% annual EBIT growth in 2025 and 2026.
  • Average one‑year price target: €73.72 - implying ~47.45% upside from the prevailing share price.
  • P/E ratio: 17.3x, indicating a moderate valuation relative to earnings.
  • Market capitalization: ~€10.2 billion (as of February 2025).
  • Dividend yield: 3.96%; payout ratio: 0.62, reflecting a balanced distribution policy.
  • Analyst revision for Depositary Receipt (AKZOY): new target $27.45, down 27.53% from prior estimate.
Metric Value Notes
JPMorgan Rating Overweight PT €70.00; EBIT growth +9% (2025-2026)
Average 1‑yr Price Target €73.72 ~47.45% implied upside vs current share price
P/E Ratio 17.3x Moderate earnings multiple
Market Capitalization €10.2 billion Feb 2025
Dividend Yield 3.96% Payout ratio 0.62
AKZOY DR Price Target $27.45 -27.53% revision

Key valuation drivers to monitor:

  • Realized EBIT trajectory vs. JPMorgan's +9%/yr assumption for 2025-26.
  • Margin stability in core coatings and specialty chemicals segments.
  • Capital allocation: dividend sustainability (3.96% yield) and buyback or reinvestment policy.
  • Currency and input-cost dynamics affecting reported earnings and DR valuation (AKZOY).

Further context on strategy and long‑term positioning: Mission Statement, Vision, & Core Values (2026) of Akzo Nobel N.V.

Akzo Nobel N.V. (AKZA.AS) - Risk Factors

  • Macroeconomic volatility: Exposure to global trade tensions (including US tariffs) and currency swings increases input cost volatility and squeezes margins. Management commentary in recent quarters flagged notable FX pressure across emerging markets.
  • Restructuring and operational disruption: Ongoing restructuring (job reductions, plant consolidations/closures) aims to reduce fixed costs but creates short‑term execution risk, potential one‑off charges and disruption to supply chains.
  • Demand weakness in key markets: Slower industrial and decorative paints demand in China and Latin America risks top‑line growth and market share in high‑growth regions.
  • Financial leverage concerns: Net debt/EBITDA has exceeded the company's stated mid‑term target range, raising refinancing and covenant sensitivity during cyclical downturns.
  • Currency headwinds in 2025: FX translation and transaction effects materially weighed on revenue and profitability in Q2 and Q3 2025, pressuring reported EUR results.
  • Divestment execution risk: The planned/announced divestment of Akzo Nobel India introduces integration and execution risks, with potential short‑term revenue loss and transitional contract/legal issues.
Metric Most Recent 12M / FY (approx.) Notes
Reported Revenue €9.5 bn Decorative & Performance Coatings mix; FX‑sensitive
Adjusted EBITDA €1.2 bn Margin pressure from raw materials and FX
Net Debt €3.7 bn Post‑restructuring financing; includes lease liabilities
Net debt / EBITDA ~3.1x Above mid‑term target (c.2.0-2.5x)
Free Cash Flow (LTM) €420 m Working capital swings and restructuring spend impacted cash conversion
Cash & Equivalents €0.6 bn Limited near‑term liquidity cushion vs gross debt
  • Operational risks detail:
    • Plant closures - potential production bottlenecks and relocation costs;
    • Headcount reductions - short‑term productivity loss and restructuring charges;
    • Supply‑chain concentration - raw‑material price spikes can erode margins quickly.
  • Market & revenue risks:
    • China: slower industrial activity could reduce volume growth by mid‑single digits annually;
    • Latin America: currency depreciation and weak end‑market demand compress nominal sales.
  • Financial risks:
    • Leverage above guidance increases sensitivity to interest rate moves and restricts strategic optionality;
    • FX translation: a sustained euro strength versus USD/BRL/CNY would continue to reduce reported EUR revenue;
    • Divestment proceeds timing: delayed or lower‑than‑expected proceeds from the India sale could delay deleveraging.
  • Execution & legal risks:
    • Complexity of divesting operations in India - regulatory approvals, buyer financing and transitional service agreements;
    • Potential one‑off restructuring and impairment charges if market recovery lags assumptions.
Mission Statement, Vision, & Core Values (2026) of Akzo Nobel N.V.

Akzo Nobel N.V. (AKZA.AS) - Growth Opportunities

Akzo Nobel is actively reshaping its portfolio and operations to capture higher-margin segments and faster-growing geographies. Key moves include a strategic review of non-core assets (notably the announced sale of Akzo Nobel India to JSW Group, expected to close in Q4 2025) and accelerated efficiency programs targeting material cost and SG&A reductions. These actions are intended to improve cash generation and free up capital for reinvestment in high-growth coatings and specialty segments.
  • Portfolio streamlining: divestment of non-core assets (India sale to JSW Group - closing expected Q4 2025) to sharpen focus on core coatings and specialties.
  • Efficiency savings: target of annualized gross savings of over €150 million by end-2025; actions are running ahead of schedule.
  • Emerging markets expansion: prioritized growth in Asia and Latin America to drive volume recovery and market share gains.
  • Strategic partnerships: collaborations such as with Nordbo Robotics to improve production automation and reduce unit costs.
  • Sustainability-driven innovation: initiatives to repurpose industrial waste into paint ingredients, offering potential raw-material cost offsets and lower CO2 footprint.
Metric / Initiative Target / Status Timeframe
Annualized gross savings target €150+ million End of 2025
Akzo Nobel India divestment Sale to JSW Group - transaction in progress Expected close Q4 2025
Emerging markets revenue growth (targeted) Mid-single to high-single digit CAGR 2024-2027 (strategic horizon)
Automation / robotics partnership Nordbo Robotics collaboration - pilot & rollout phases Ongoing 2024-2026
Sustainability product initiatives Pilot commercialisation of recycled industrial waste inputs 2024-2025 scale-up
Opportunities tied to emerging-market expansion and divestments are expected to change the company's geographic mix and margin profile. Growth dynamics to monitor:
  • Asia: continued urbanization and construction activity - coatings demand growth estimated in the mid-single-digit range annually, with faster recovery in decorative and protective segments.
  • Latin America: selective country recoveries and infrastructure projects supporting mid-single-digit demand growth.
  • Product mix shift: premium, sustainable and industrial coatings delivering higher margin uplift versus basic decorative paints.
Operational improvements and portfolio moves also influence capital allocation and valuation drivers:
Area Implication for Investors
Cost savings realization Improves operating margins, supports EPS upside and deleverages the balance sheet.
Divestments (e.g., India) Generates proceeds for share buybacks, debt reduction or reinvestment into growth businesses.
Emerging markets expansion Presents volume upside and diversification; execution risk is country-specific.
Sustainability & innovation Potential to lower input costs, meet regulatory demands, and access premium pricing.
For historical context on Akzo Nobel's strategy, ownership and how the company generates revenue consult Akzo Nobel N.V.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Akzo Nobel N.V. (AKZA.AS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.